Abstract
The intravenous administration of naloxone 2 min before coronary artery occlusion in anaesthetized dogs reduced the incidence and severity of cardiac arrhythmias during coronary occlusion (20 min) and reperfusion (120 min) in a dose-related manner. It also reduced the mortality. At a dose of 1 mg kg-1 (the maximum dose used in this study) naloxone abolished the appearance of the life threatening ventricular fibrillation (VF) and ventricular tachycardia (VT) and as a consequence all dogs in this group survived. The results suggest a possible involvement of endogenous opioid peptides in arrhythmogenesis during coronary occlusion and reperfusion in the dog.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benfey B. G., Elfellah M. S., Ogilvie R. I., Varma D. R. Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs. Br J Pharmacol. 1984 Jul;82(3):717–725. doi: 10.1111/j.1476-5381.1984.tb10811.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bergey J. L., Beil M. E. Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs. Eur J Pharmacol. 1983 Jun 17;90(4):427–431. doi: 10.1016/0014-2999(83)90566-6. [DOI] [PubMed] [Google Scholar]
- Fagbemi O., Leprán I., Parratt J. R., Szekeres L. Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol. 1982 Aug;76(4):504–506. doi: 10.1111/j.1476-5381.1982.tb09246.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Penny W. J., Sheridan D. J. Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion. Cardiovasc Res. 1983 Jun;17(6):363–372. doi: 10.1093/cvr/17.6.363. [DOI] [PubMed] [Google Scholar]